SN38-loaded nanomedicine mediates chemo-radiotherapy against CD44-expressing cancer growth

Shu Jyuan Yang, Jui An Pai, Cheng Jung Yao, Chung Huan Huang, Jenny Ling‑Yu Chen, Chung Hao Wang, Ke Cheng Chen, Ming Jium Shieh

研究成果: 雜誌貢獻文章同行評審

1 引文 斯高帕斯(Scopus)


Background: Chemo-radiotherapy is the combined chemotherapy and radiotherapy on tumor treatment to obtain the local radiosensitization and local cytotoxicity of the tumor and to control the microscopic metastatic disease. Methods: In this study, 7-ethyl-10-hydroxycamptothecin (SN38) molecules could be successfully loaded into human serum albumin (HSA)–hyaluronic acid (HA) nanoparticles (SH/HA NPs) by the hydrophobic side groups of amino acid in HSA. Results: HSA could be used to increase the biocompatibility and residence time of the nanoparticles in the blood, whereas HA could improve the benefits and overall treatment effect on CD44-expressing colorectal cancer (CRC), and reduce drug side effects. In addition to its role as a chemotherapeutic agent, SN38 could be used as a radiosensitizer, able to arrest the cell cycle, and allowing cells to stay in the G2/M stage, to improve the sensitivity of tumor cells to radiation. In vivo results demonstrated that SH/HA NPs could accumulate in the tumor and produce significant tumor suppression, with no adverse effects observed when combined with γ-ray irradiation. This SH/HA NPs-medicated chemo-radiotherapy could induce an anti-tumor immune response to inhibit the growth of distal tumors, and produce an abscopal effect. Conclusions: Therefore, this SN38-loaded and HA-incorporated nanoparticle combined with radiotherapy may be a promising therapeutic artifice for CRC in the future.

期刊Cancer Nanotechnology
出版狀態已發佈 - 12月 2023

ASJC Scopus subject areas

  • 生物醫學工程
  • 腫瘤科
  • 藥學科學
  • 物理與理論化學


深入研究「SN38-loaded nanomedicine mediates chemo-radiotherapy against CD44-expressing cancer growth」主題。共同形成了獨特的指紋。